Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Shares, with no par value
-
Shares outstanding
-
50,973,571
-
Number of holders
-
8
-
Total 13F shares, excl. options
-
1,727,190
-
Shares change
-
+1,727,190
-
Total reported value, excl. options
-
$4,433,025
-
Value change
-
+$4,433,025
-
Number of buys
-
8
-
Price
-
$2.58
Institutional Holders of EUPRAXIA PHARMACEUTICALS INC. - Common Shares, with no par value (EPRX) as of Q2 2024
8 filings reported holding EPRX - EUPRAXIA PHARMACEUTICALS INC. - Common Shares, with no par value as of 30 Jun 2024.
EUPRAXIA PHARMACEUTICALS INC. - Common Shares, with no par value (EPRX) had 8 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 1,727,190 shares of stock of the company.
Largest 8 holders included SCOTIA CAPITAL INC., Royal Bank of Canada, BANK OF MONTREAL /CAN/, UBS Group AG, 180 WEALTH ADVISORS, LLC, JPMORGAN CHASE & CO, Federation des caisses Desjardins du Quebec, and TORONTO DOMINION BANK.
This table shows the top 8 institutional shareholders of the security as of 30 Jun 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.